Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Biotechniques|March 26, 2008
Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assayMark Abramovitz, Maja Ordanic-Kodani, Yuefang Wang, et al.Plos One|February 2, 2011
The effect of a DNA repair gene on cellular invasiveness: XRCC3 over-expression in breast cancer cellsVeronica L Martinez-Marignac, Amélie Rodrigue, David Davidson, et al.JCO Precision Oncology|September 11, 2020
Exploratory Analysis of Single-Gene Predictive Biomarkers in HERA DASL Cohort Reveals That C8A mRNA Expression Is Prognostic of Outcome and Predictive of Benefit of TrastuzumabScooter Willis, Varvara Polydoropoulou, Yuliang Sun, et al.American Journal of Respiratory Cell and Molecular Biology|June 11, 2005
Gob-5 is not essential for mucus overproduction in preclinical murine models of allergic asthmaAnnette Robichaud, Stephanie A Tuck, Stacia Kargman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA TrialMitch Dowsett, Marion Procter, Worta McCaskill-Stevens, et al.BMC Cancer|November 12, 2013
Wnt signaling in triple negative breast cancer is associated with metastasisNandini Dey, Benjamin G Barwick, Carlos S Moreno, et al.The American Journal of Pathology|June 28, 2011
Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomyQi Long, Brent A Johnson, Adeboye O Osunkoya, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Recommendations for collection and handling of specimens from group breast cancer clinical trialsBrian R Leyland-Jones, Christine B Ambrosone, John Bartlett, et al.Oncotargets and Therapy|December 15, 2015
A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapyCasey B Williams, Caitlin McMahon, Siraj M Ali, et al.JCO Precision Oncology|September 11, 2020
High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple CancersScooter Willis, Yuliang Sun, Mark Abramovitz, et al.Pageof 3